Whitepaper: Leveraging the patient journey to optimise injection device use at home
Posted: 25 March 2020 | Nemera | No comments yet
With the growing trend of injection device use at home, the device optimisation is essential to increase patient safety during self-administration.
The growing prevalence of chronic diseases, along with the evolution of patients’ lifestyles, is driving new ways of administrating parenteral drugs. Novel treatments have become available, with the majority arising from biological molecules. Biologic drugs are predominantly administered via injectable devices, using prefilled syringes as a base. This is why it is important to optimise the device to increase patient safety during self-administration of medication.
Related content from this organisation
Related topics
Biopharmaceuticals, Drug Delivery Systems, Research & Development (R&D)